M K Proteins Ratios

M K Proteins Ltd Ratios

The M K Proteins Ltd Ratios page provides a complete fundamental analysis of M K Proteins Ltd using key valuation, profitability, and financial strength metrics. Investors tracking M K Proteins Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

M K Proteins Ltd (NSE: MKPL, BSE: 543919) is currently trading at ₹5.33, with a market capitalization of ₹1.98B. As a major player in the Process industries sector and Agricultural commodities/Milling industry, M K Proteins Ltd remains a key stock for fundamental analysis using M K Proteins Ltd Ratios.

M K Proteins Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The M K Proteins Ltd P/E ratio currently stands at 27, making it one of the most tracked metrics in M K Proteins Ltd Ratios.

Historically, the M K Proteins Ltd P/E ratio has shown strong fluctuations:

• 2024: 27
• 2023: 33.08
• 2022: 83.53
• 2021: 7.84
• 2020: 3.19

The decline in M K Proteins Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The M K Proteins Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 3.26.

Historical P/B trend:

• 2024: 3.26
• 2023: 6.07
• 2022: 18.32
• 2021: 2.02

M K Proteins Ltd is trading at a premium to its book value, indicating strong market confidence.

Price to Sales Ratio (P/S)

The M K Proteins Ltd P/S ratio currently stands at 0.85, an important part of M K Proteins Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 0.85
• 2023: 1.51
• 2022: 2.90
• 2021: 0.31

A stable or declining M K Proteins Ltd P/S ratio indicates cautious market sentiment.

M K Proteins Ltd Price to Cash Flow Ratio (P/CF)

The M K Proteins Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical M K Proteins Ltd Price to Cash Flow Ratio:

• 2024: 0
• 2023: 11.78
• 2022: 0
• 2021: 0
• 2020: 5.98

The declining M K Proteins Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

M K Proteins Ltd Enterprise Value Ratios

Enterprise Value (EV)

The M K Proteins Ltd EV currently stands at ₹2.65B, representing the total company valuation including debt.

Historical EV trend:

• 2024: 2.65B
• 2023: 3.91B
• 2022: 9.59B
• 2021: 1.17B

M K Proteins Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The M K Proteins Ltd EV/EBITDA ratio is currently 20.69, a key metric in M K Proteins Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 20.69
• 2023: 22.63
• 2022: 54.05
• 2021: 7.37

Stable M K Proteins Ltd EV/EBITDA indicates balanced valuation.

M K Proteins Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The M K Proteins Ltd D/E ratio is currently 0.56, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.56
• 2023: 0.33
• 2022: 0.91
• 2021: 0.93

M K Proteins Ltd maintains moderate leverage with manageable risk.

Return on Equity (ROE %)

The M K Proteins Ltd ROE currently stands at 12.87%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 12.87
• 2023: 20.14
• 2022: 24.44
• 2021: 29.54

M K Proteins Ltd maintains stable profitability levels.

M K Proteins Ltd Ratios Analysis Summary

The M K Proteins Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether M K Proteins Ltd stock is undervalued, fairly valued, or overvalued.

Tracking M K Proteins Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.